| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-125 |
Sentence |
denotes |
Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus. |
| T2 |
126-145 |
Sentence |
denotes |
BACKGROUND AND AIM: |
| T3 |
146-285 |
Sentence |
denotes |
Total glucosides of paeony (TGP), an active compound extracted from dried roots of Paeonia lactiflora Pall, have anti-inflammatory effects. |
| T4 |
286-421 |
Sentence |
denotes |
This study investigated the efficacy and safety of TGP for treating diabetic kidney disease (DKD) in type 2 diabetes mellitus patients. |
| T5 |
422-430 |
Sentence |
denotes |
METHODS: |
| T6 |
431-536 |
Sentence |
denotes |
An open-label, prospective, randomized, parallel-group, single-site study involving 76 patients with DKD. |
| T7 |
537-740 |
Sentence |
denotes |
Patients were randomized into two groups: losartan group (n = 38), treated with losartan 100 mg/day for 6 months and TGP group (n = 38), treated with TGP 1800 mg/day and losartan 100 mg/day for 6 months. |
| T8 |
741-815 |
Sentence |
denotes |
Serum hs-CRP, MCP-1, and TNF-α were determined before and after treatment. |
| T9 |
816-929 |
Sentence |
denotes |
Urinary albumin excretion rate (UAER), fasting blood glucose, serum creatinine, and lipid profiles were examined. |
| T10 |
930-938 |
Sentence |
denotes |
RESULTS: |
| T11 |
939-1012 |
Sentence |
denotes |
At the end-point, UAER decreased in the TGP group compared with baseline. |
| T12 |
1013-1089 |
Sentence |
denotes |
UAER in the losartan group decreased to a level lower than before treatment. |
| T13 |
1090-1175 |
Sentence |
denotes |
The rate of decline in the losartan group was significantly lower than the TGP group. |
| T14 |
1176-1302 |
Sentence |
denotes |
There were no significant differences in serum creatinine and albumin levels between TGP and losartan groups at the end-point. |
| T15 |
1303-1397 |
Sentence |
denotes |
Serum hs-CRP, MCP-1, and TNF-α levels were significantly lower in both groups after treatment. |
| T16 |
1398-1502 |
Sentence |
denotes |
After treatment, serum hs-CRP, MCP-1, and TNF-α in the TGP group decreased more than the losartan group. |
| T17 |
1503-1581 |
Sentence |
denotes |
Positive correlations were observed between UAER and hs-CRP, MCP-1, and TNF-α. |
| T18 |
1582-1666 |
Sentence |
denotes |
No statistically significant difference in side effects was observed between groups. |
| T19 |
1667-1678 |
Sentence |
denotes |
CONCLUSION: |
| T20 |
1679-1815 |
Sentence |
denotes |
Our study showed that TGP treatment could reduce the albuminuria and inflammatory markers in type 2 diabetes mellitus patients with DKD. |
| T1 |
0-125 |
Sentence |
denotes |
Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus. |
| T2 |
126-145 |
Sentence |
denotes |
BACKGROUND AND AIM: |
| T3 |
146-285 |
Sentence |
denotes |
Total glucosides of paeony (TGP), an active compound extracted from dried roots of Paeonia lactiflora Pall, have anti-inflammatory effects. |
| T4 |
286-421 |
Sentence |
denotes |
This study investigated the efficacy and safety of TGP for treating diabetic kidney disease (DKD) in type 2 diabetes mellitus patients. |
| T5 |
422-430 |
Sentence |
denotes |
METHODS: |
| T6 |
431-536 |
Sentence |
denotes |
An open-label, prospective, randomized, parallel-group, single-site study involving 76 patients with DKD. |
| T7 |
537-740 |
Sentence |
denotes |
Patients were randomized into two groups: losartan group (n = 38), treated with losartan 100 mg/day for 6 months and TGP group (n = 38), treated with TGP 1800 mg/day and losartan 100 mg/day for 6 months. |
| T8 |
741-815 |
Sentence |
denotes |
Serum hs-CRP, MCP-1, and TNF-α were determined before and after treatment. |
| T9 |
816-929 |
Sentence |
denotes |
Urinary albumin excretion rate (UAER), fasting blood glucose, serum creatinine, and lipid profiles were examined. |
| T10 |
930-938 |
Sentence |
denotes |
RESULTS: |
| T11 |
939-1012 |
Sentence |
denotes |
At the end-point, UAER decreased in the TGP group compared with baseline. |
| T12 |
1013-1089 |
Sentence |
denotes |
UAER in the losartan group decreased to a level lower than before treatment. |
| T13 |
1090-1175 |
Sentence |
denotes |
The rate of decline in the losartan group was significantly lower than the TGP group. |
| T14 |
1176-1302 |
Sentence |
denotes |
There were no significant differences in serum creatinine and albumin levels between TGP and losartan groups at the end-point. |
| T15 |
1303-1397 |
Sentence |
denotes |
Serum hs-CRP, MCP-1, and TNF-α levels were significantly lower in both groups after treatment. |
| T16 |
1398-1502 |
Sentence |
denotes |
After treatment, serum hs-CRP, MCP-1, and TNF-α in the TGP group decreased more than the losartan group. |
| T17 |
1503-1581 |
Sentence |
denotes |
Positive correlations were observed between UAER and hs-CRP, MCP-1, and TNF-α. |
| T18 |
1582-1666 |
Sentence |
denotes |
No statistically significant difference in side effects was observed between groups. |
| T19 |
1667-1678 |
Sentence |
denotes |
CONCLUSION: |
| T20 |
1679-1815 |
Sentence |
denotes |
Our study showed that TGP treatment could reduce the albuminuria and inflammatory markers in type 2 diabetes mellitus patients with DKD. |